Investors.
Sciensus proudly sitting at the intersection of patients and their medicine
Sciensus is a global life sciences company specializing in market-leading patient access, engagement and insight solutions. With an international presence, we sit proudly at the intersection of patients and their medicine, specifically those with chronic and long-term conditions, rare diseases and cancer.
Harnessing the power of more than 70 million patient interactions, captured through our advanced patient apps and digital platforms, we uncover vital insight into patient experience and the drivers of medicine adherence. Powered by these interactions, we develop and deliver innovative patient support programs and generate invaluable real-world insight to enable clinicians and pharmaceutical companies to drive better outcomes for patients.
Our approach
Engaging and empowering patients to become more active participants in their health is key to driving positive change in healthcare. Our unparalleled patient-reported data and insights, cutting-edge research and smart, intuitive technology are designed to connect with people powerfully and personally, focusing on their unique needs and supporting them every step of the way.
Our markets
With a goal to increasing patient engagement with life-changing treatment and medication, our focus is on chronic conditions, cancer and rare diseases.
Our services
Our bespoke, end-to-end services, built on exceptional insight and experience in our key markets, connect pharmaceutical companies, insurers and healthcare professionals to patients through our advanced digital health technology.
Strategy and objectives
We recognize the world is changing faster than ever. New technologies have reshaped the way we live, redrawn the healthcare landscape and redefined the expectations of patients everywhere. At Sciensus, we are pioneering a new era of digitally-enabled patient benefits.
Our vision
To be the global leader in helping each and every patient make the most of their medicine.
Our mission
To give patients control of their health through knowledge, choice, convenience and connection.
Passionate about patients
Ambitious to be the best
Together, we win
Financials
Making a positive impact
How we’re taking responsibility through our Environmental, Social & Governance strategy.
Our digital solutions
Patients are at the heart of our strategy. By empowering and supporting them we work with other parts of the health eco-system to drive better health outcomes. Our growth plans rest on this patient centricity and a commitment to quality, earning us the right to deliver more value-added services to our customers.
We’re continuous innovating and investing is our digital health solutions, including portals for the NHS, clinicians, pharmaceutical companies, life science companies and European hospital pharmacies. We’ve also developed impactful patient apps and an online patient community.
News & Insights
Blogs/Articles
Four considerations before collecting real-world data in your EAP
Expanded access programs (EAPs) for rare disease medications present a valuable opportunity for biotechs to collect real-world data (RWD). In…
Blogs/Articles
The increasing importance of real-world data for the EMA
Over recent years, real-world data (RWD) has become a critical element of the development and commercialization of medications. RWD includes…
Blogs/Articles
Six steps for a successful Expanded Access Program in Europe
For biotech companies seeking to bring a new rare disease treatment to market in Europe, there can be many obstacles…
Partner with experience and expertise
If you’d like to find out how our partnerships can power your business, just contact us.